DANISH BIO – DANSK BIOTEK organizes four major plenary meetings for our members throughout the year to increase our members' knowledge regarding specific biotech topics and to facilitate networking. The events usually take place in February, May, September and November.

We also organize approximately four "saloon" meetings annually. They are small, intimate, "meet the expert" meetings with typically 6-20 participants advocating more in-depth discussion and knowledge-sharing on specific themes.

News

Generalforsamling i DANISH BIO – DANSK BIOTEK 2017 05 May 2017

DANISH BIO – DANSK BIOTEK afholdt i år ordinær generalforsamling den 4. maj hos Novo Nordisk i forbindelse... Read more

Bionedbrydelig kugle og mordgåder bag tildeling af Novo Nordisk Fondens Gymnasielærerpris 2017 28 April 2017

Gymnasielærere i Bagsværd i Nordsjælland og Paderum ved Randers modtager Novo Nordisk Fondens Gymnasielærerpris... Read more

Life science i verdensklasse 03 April 2017

Anbefalinger fra regeringens vækstteam for life science Marts 2017 >>

Analyse af perspektiver og vækstbarrierer for udvikling af dansk biotek 27 March 2017

Analyse af perspektiver og vækstbarrierer for udvikling af dansk biotek IRIS Group har netop publiceret... Read more

YmAbs’ 131I-8H9 Receives EU Orphan Drug Designation 03 March 2017

Y-mAbs Therapeutics, Inc. receives first European Orphan Drug Designation NEW YORK, March 1, 2017 –... Read more

Gymnasielærerprisen 2017 fra DANISH BIO – DANSK BIOTEK og Novo Nordisk Fonden 15 February 2017

Indstillingsskema Novo Nordisk Fondens Gymnasielærerpris 2017 Opslag Novo Nordisk Fondens Gymnasielærerpris... Read more

DANISH BIO – DANSK BIOTEK støtter op om de syv grundprincipper for lige og åben adgang til sundhedsdata 25 January 2017

7 principper for sundhedsdata >>

Forward Pharma Agrees to Enter Into Settlement and License Agreement with Biogen 19 January 2017

Biogen will pay Forward a non-refundable cash fee of $1.25 billion Forward may be eligible to receive... Read more

YmAbs Raises $12 Million in Equity Funding 10 January 2017

Y-mAbs Therapeutics, Inc. closes $12 million in private placement among current shareholders NEW YORK,... Read more

Copyright 2017 DANISH BIO – DANSK BIOTEK. All rights reserved.

created by: Mastafu Design